ARCA biopharma Inc (ABIO)
3.58
+0.10
(+2.87%)
USD |
NASDAQ |
Apr 26, 16:00
3.58
0.00 (0.00%)
After-Hours: 18:27
ARCA biopharma Price to Book Value: 1.402 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 1.363 |
April 24, 2024 | 1.422 |
April 23, 2024 | 1.430 |
April 22, 2024 | 1.351 |
April 19, 2024 | 1.332 |
April 18, 2024 | 1.273 |
April 17, 2024 | 1.257 |
April 16, 2024 | 1.281 |
April 15, 2024 | 1.246 |
April 12, 2024 | 1.265 |
April 11, 2024 | 1.273 |
April 10, 2024 | 1.23 |
April 09, 2024 | 1.226 |
April 08, 2024 | 1.175 |
April 05, 2024 | 1.210 |
April 04, 2024 | 1.206 |
April 03, 2024 | 1.273 |
April 02, 2024 | 0.6698 |
April 01, 2024 | 0.6855 |
March 28, 2024 | 0.6894 |
March 27, 2024 | 0.6855 |
March 26, 2024 | 0.6698 |
March 25, 2024 | 0.6777 |
March 22, 2024 | 0.6933 |
March 21, 2024 | 0.6972 |
Date | Value |
---|---|
March 20, 2024 | 0.6855 |
March 19, 2024 | 0.6816 |
March 18, 2024 | 0.6737 |
March 15, 2024 | 0.662 |
March 14, 2024 | 0.6659 |
March 13, 2024 | 0.662 |
March 12, 2024 | 0.6502 |
March 11, 2024 | 0.6444 |
March 08, 2024 | 0.6424 |
March 07, 2024 | 0.6385 |
March 06, 2024 | 0.6502 |
March 05, 2024 | 0.6542 |
March 04, 2024 | 0.6581 |
March 01, 2024 | 0.6542 |
February 29, 2024 | 0.6463 |
February 28, 2024 | 0.6542 |
February 27, 2024 | 0.662 |
February 26, 2024 | 0.6463 |
February 23, 2024 | 0.6385 |
February 22, 2024 | 0.6385 |
February 21, 2024 | 0.6372 |
February 20, 2024 | 0.6424 |
February 16, 2024 | 0.6542 |
February 15, 2024 | 0.6463 |
February 14, 2024 | 0.6424 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.486
Minimum
Mar 18 2020
4.856
Maximum
May 28 2020
0.9457
Average
0.7529
Median
Jul 06 2023
Price to Book Value Benchmarks
Shockwave Medical Inc | 18.46 |
Asensus Surgical Inc | 2.024 |
Glaukos Corp | 10.82 |
Helius Medical Technologies Inc | 1.722 |
Perspective Therapeutics Inc | 12.41 |
Price to Book Value Related Metrics
Price | 3.58 |
Earnings Yield | -10.34% |
Market Cap | 51.91M |